Literature DB >> 23446655

Correlation of spectral domain optical coherence tomography characteristics with visual acuity in eyes with subfoveal scarring after treatment for wet age-related macular degeneration.

Sharif El-Emam1, Jay Chhablani, Giulio Barteselli, Haiyan Wang, Su Na Lee, Igor Kozak, Lingyun Cheng, William R Freeman.   

Abstract

PURPOSE: Correlating spectral domain optical coherence tomography characteristics with final best-corrected visual acuity (BCVA) in eyes with subfoveal scarring after treatment for wet age-related macular degeneration.
METHODS: Seventy-nine eyes from 64 subjects, who developed subfoveal scarring after treatment of wet age-related macular degeneration, were retrospectively studied. Spectral domain optical coherence tomography characteristics were analyzed, including percentage disruption of inner segment/outer segment junction and external limiting membrane, central macular thickness, subfoveal scar thickness, subretinal scar area, and proximity of retina with intact outer structures to the fovea. A multivariate stepwise regression analysis was performed with the final BCVA logarithm of minimum angle of resolution as a response and the above-identified spectral domain optical coherence tomography variables as predictors.
RESULTS: There was no correlation between the final BCVA and any of the demographic data, treatment modality received, and central macular thickness. The final BCVA was significantly correlated with the percentage of inner segment/outer segment disruption (P = 0.011), external limiting membrane disruption (P = 0.005), and scar area on spectral domain optical coherence tomography (P = 0.018). Multivariate analysis showed that the baseline BCVA and distance between the fovea and nearest retina with intact outer structures are the most predictive of the final BCVA (R(2) = 0.52).
CONCLUSION: Baseline BCVA and integrity of outer retinal structures are good predictors of the final BCVA of wet age-related macular degeneration patients developing scarring after treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23446655     DOI: 10.1097/IAE.0b013e31827b6439

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  5 in total

1.  The Project MACULA Retinal Pigment Epithelium Grading System for Histology and Optical Coherence Tomography in Age-Related Macular Degeneration.

Authors:  Emma C Zanzottera; Jeffrey D Messinger; Thomas Ach; R Theodore Smith; K Bailey Freund; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

2.  Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion.

Authors:  Joon-Won Kang; Hyungwoo Lee; Hyewon Chung; Hyung Chan Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-01       Impact factor: 3.117

3.  Longitudinal Assessment of Ellipsoid Zone Integrity, Subretinal Hyperreflective Material, and Subretinal Pigment Epithelium Disease in Neovascular Age-Related Macular Degeneration.

Authors:  Justis P Ehlers; Robert Zahid; Peter K Kaiser; Jeffrey S Heier; David M Brown; Xiangyi Meng; Jamie Reese; Thuy K Le; Leina Lunasco; Ming Hu; Sunil K Srivastava
Journal:  Ophthalmol Retina       Date:  2021-02-26

4.  Visual function assessment in simulated real-life situations in HIV-infected subjects.

Authors:  Giulio Barteselli; Jay Chhablani; Maria Laura Gomez; Aubrey L Doede; Laurie Dustin; Igor Kozak; Dirk-Uwe Bartsch; Stanley P Azen; Scott L Letendre; William R Freeman
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

5.  12-month results of the standardised combination therapy for diabetic macular oedema: intravitreal bevacizumab and navigated retinal photocoagulation.

Authors:  Giulio Barteselli; Igor Kozak; Sharif El-Emam; Jay Chhablani; Marco A Cortes; William R Freeman
Journal:  Br J Ophthalmol       Date:  2014-04-10       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.